Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v5-EN
Language English English
Date Updated 2018-10-02 2018-09-25
Drug Identification Number 02439379 02439379
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name ROPIVACAINE HYDROCHLORIDE INJECTION, USP ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients ROPIVACAINE HYDROCHLORIDE ROPIVACAINE HYDROCHLORIDE
Strength(s) 2mg/mL 2mg/mL
Dosage form(s) Solution Solution
Route of administration Epidural, Infiltration Epidural, Infiltration
Packaging size 100 mL bag 100 mL bag
ATC code N01BB N01BB
ATC description Anesthetics. Local Anesthetics. Local
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-06-01 2018-06-01
Estimated end date 2018-09-21
Actual end date 2018-10-01 2018-10-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments This product will be available through all MDP and McKesson locations effective Monday October 1, 2018. This product will be available through all MDP and McKesson locations effective Monday October 1, 2018.
Health Canada comments